The CEO of Eli Lilly, Dave Ricks, announced that Medicare’s decision to cover Ozempic and other GLP-1 medications could significantly reshape weight loss treatment options in...
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has denied approval for Eli Lilly’s weight management drug Mounjaro as a treatment for...
Eli Lilly has officially reached a market capitalization of $1 trillion, marking a significant milestone as the first publicly traded company in the healthcare sector to...
Novo Nordisk has announced a significant reduction in the price of its weight-loss drug Wegovy, cutting the monthly cost for uninsured patients to $349, down from...
The Trump administration is currently in negotiations with pharmaceutical companies Novo Nordisk and Eli Lilly to potentially lower prices for their popular weight loss medications, including...
The US Food and Drug Administration (FDA) has granted clearance to a new blood test designed to assist in assessing the likelihood of Alzheimer’s disease in...
A federal judge in Delaware has dismissed a lawsuit filed by Eli Lilly, the manufacturer of popular weight loss drugs Mounjaro and Zepbound, against Strive Pharmacy,...
A federal judge in Delaware has dismissed a lawsuit filed by Eli Lilly, the manufacturer of the popular weight loss medications Mounjaro and Zepbound, against Strive...
Eli Lilly has unveiled a new innovation hub, Gateway Labs, in San Diego, aimed at nurturing biotechnology startups and enhancing its own pharmaceutical pipeline. The launch...
Eli Lilly has reported promising results from its latest Phase III trial of an experimental oral medication designed to combat obesity. The drug, known as orforglipron,...
